People: Adamas Pharmaceuticals Inc (ADMS.OQ)

ADMS.OQ on NASDAQ Stock Exchange Global Market

1:30am IST
Change (% chg)

$0.05 (+0.80%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Went, Gregory 

Dr. Gregory T. Went, Ph.D., serves as Chairman of the Board, Chief Executive Officer, Co-Founder of Adamas Pharmaceuticals, Inc. Previously, Dr. Went co-founded CuraGen Corporation in 1992, where he served as an Executive Vice President and director from 1996 to 1999. Dr. Went also has served as a director of Angelica Therapeutics, Inc., a biotechnology company, since 2006. Dr. Went holds a Ph.D. in Chemical Engineering from the University of California, Berkeley and a B.S. in Chemical Engineering from Carnegie Mellon University. We believe Dr. Went’s extensive knowledge of our company, the pharmaceutical industry, and our competitors qualifies him to serve on our Board of Directors.

Basic Compensation

Total Annual Compensation, USD 810,200
Restricted Stock Award, USD 529,238
Long-Term Incentive Plans, USD --
All Other, USD 2,019,680
Fiscal Year Total, USD 3,359,120

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --